Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Blood sugar control In the SURPASS-2 head-to-head trial (NCT03987919), tirzepatide reduced HbA1c by up to 2.30%, compared with 1.86% for semaglutide
Instead of traditional batch processing, continuous manufacturing involves a constant flow of production, which can lead to higher yields and more consistent quality
Significant weight loss from any method can temporarily affect menstrual regularity
The IGF-1R is mainly involved in regulation of cell proliferation, antiapoptosis, differentiation and cell motility, whereas IR is mostly of impact for control of glucose uptake and metabolism
This triple mechanism distinguishes it from existing approved treatments such as semaglutide (a GLP-1 agonist) or tirzepatide (a dual GIP/GLP-1 agonist)
